Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Curcumin and docosahexaenoic acid block insulin-induced colon carcinoma cell proliferation.

Fenton JI, McCaskey SJ.

Prostaglandins Leukot Essent Fatty Acids. 2013 Mar;88(3):219-26. doi: 10.1016/j.plefa.2012.11.010. Epub 2012 Dec 23.

PMID:
23266210
2.

Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.

Lee JY, Lee YM, Chang GC, Yu SL, Hsieh WY, Chen JJ, Chen HW, Yang PC.

PLoS One. 2011;6(8):e23756. doi: 10.1371/journal.pone.0023756. Epub 2011 Aug 17.

3.

A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Altenburg JD, Bieberich AA, Terry C, Harvey KA, Vanhorn JF, Xu Z, Jo Davisson V, Siddiqui RA.

BMC Cancer. 2011 Apr 21;11:149. doi: 10.1186/1471-2407-11-149.

4.

Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.

Sreekanth CN, Bava SV, Sreekumar E, Anto RJ.

Oncogene. 2011 Jul 14;30(28):3139-52. doi: 10.1038/onc.2011.23. Epub 2011 Feb 14.

PMID:
21317920
5.

Characterization of synergistic anti-cancer effects of docosahexaenoic acid and curcumin on DMBA-induced mammary tumorigenesis in mice.

Siddiqui RA, Harvey KA, Walker C, Altenburg J, Xu Z, Terry C, Camarillo I, Jones-Hall Y, Mariash C.

BMC Cancer. 2013 Sep 13;13:418. doi: 10.1186/1471-2407-13-418.

6.

Curcumin is a biologically active copper chelator with antitumor activity.

Zhang W, Chen C, Shi H, Yang M, Liu Y, Ji P, Chen H, Tan RX, Li E.

Phytomedicine. 2016 Jan 15;23(1):1-8. doi: 10.1016/j.phymed.2015.11.005. Epub 2015 Dec 4.

PMID:
26902401
7.

Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.

Chen A, Xu J.

Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G447-56. Epub 2004 Oct 14.

8.

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.

Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Rivera BK, Kálai T, Hideg K, Kuppusamy P.

Cancer Biol Ther. 2011 Nov 1;12(9):837-45. doi: 10.4161/cbt.12.9.17713. Epub 2011 Nov 1.

PMID:
21885917
9.
10.

Obesity-induced increase in tumor necrosis factor-α leads to development of colon cancer in mice.

Flores MB, Rocha GZ, Damas-Souza DM, Osório-Costa F, Dias MM, Ropelle ER, Camargo JA, de Carvalho RB, Carvalho HF, Saad MJ, Carvalheira JB.

Gastroenterology. 2012 Sep;143(3):741-53.e1-4. doi: 10.1053/j.gastro.2012.05.045. Epub 2012 Jun 4.

PMID:
22677195
12.

Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells.

Lee YK, Park SY, Kim YM, Park OJ.

Ann N Y Acad Sci. 2009 Aug;1171:489-94. doi: 10.1111/j.1749-6632.2009.04699.x.

PMID:
19723094
13.

C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.

Chen C, Liu Y, Chen Y, Xu J.

Cancer Biol Ther. 2011 Nov 1;12(9):797-807. doi: 10.4161/cbt.12.9.17671. Epub 2011 Nov 1.

PMID:
21900746
14.

Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.

Lin L, Liu Y, Li H, Li PK, Fuchs J, Shibata H, Iwabuchi Y, Lin J.

Br J Cancer. 2011 Jul 12;105(2):212-20. doi: 10.1038/bjc.2011.200. Epub 2011 Jun 21.

15.

Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.

Tang XQ, Bi H, Feng JQ, Cao JG.

Acta Pharmacol Sin. 2005 Aug;26(8):1009-16.

16.

Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.

Song KS, Jing K, Kim JS, Yun EJ, Shin S, Seo KS, Park JH, Heo JY, Kang JX, Suh KS, Wu T, Park JI, Kweon GR, Yoon WH, Hwang BD, Lim K.

Pancreatology. 2011;11(6):574-84. doi: 10.1159/000334468. Epub 2011 Dec 31.

PMID:
22213040
18.

Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation.

Khan NA, Nishimura K, Aires V, Yamashita T, Oaxaca-Castillo D, Kashiwagi K, Igarashi K.

J Lipid Res. 2006 Oct;47(10):2306-13. Epub 2006 Jul 17.

19.

Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer.

Xu Y, Zhang J, Han J, Pan X, Cao Y, Guo H, Pan Y, An Y, Li X.

Mol Oncol. 2012 Aug;6(4):405-17. doi: 10.1016/j.molonc.2012.03.005. Epub 2012 Apr 2.

20.

Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.

Liang YJ, Hao Q, Wu YZ, Wang QL, Wang JD, Hu YL.

Int J Gynecol Cancer. 2009 Oct;19(7):1248-52. doi: 10.1111/IGC.0b013e3181b33d76.

PMID:
19823063

Supplemental Content

Support Center